Cyproheptadine
Sold as Zyactin, Cyproheptadine zydus, Actincypro, Periactin
1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine
Drag to rotate. Structure from PubChem CID 2913.
Background
Registration
- Applicants
- 4
- Registrations
- 6
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) Ltd | Zyactin, Cyproheptadine zydus | 4 mg | 550847, 550848.847 | S2 | PIPIL |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Actincypro | 4 mg | 570019 | S2 | PIPIL |
| Mc Pharma (Pty) Ltd | Periactin | Not stated | A400161 | Not determined | None |
| Msd (Pty) Ltd | Periactin | syrup | C0521, C0522 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Zyactin EACH TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE EQUIVALENT TO CYPROHEPTADINE 4,0 mg | 4 mgTablets. | 55084755/5.7.1/0847Approved 6 February 2024 | Registered | S2 | PIPIL |
| Cyproheptadine zydus EACH TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE EQUIVALENT TO CYPROHEPTADINE 4,0 mg | Not listed | 550848.84755/5.7.1/0848.847 | Registered | Not determined | None |
| Actincypro EACH TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE 4,0 mg | 4 mgTablets | 57001957/5.7.1/0019Approved 29 January 2025 | Registered | S2 | PIPIL |
| Periactin EACH TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE 4,0 mg | Not listed | A400161A40/5.7.1/0161 | Registered | Not determined | None |
| Periactin EACH TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE A 4 mg | Not listed | C0521 | Old Medicine | Not determined | None |
| Periactin syrup EACH 5 ml CONTAINS CYPROHEPTADINE HYDROCHLORIDE A 2,27 mg | Syrup | C0522 | Old Medicine | Not determined | None |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S5; the leaflet's S2 applies to this product.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cyproheptadine hydrochloride equivalent to cyproheptadine
S5: Cyproheptadine
- except when indicated for allergic rhinitis or antipruritic use.
Consolidated Schedules 06 July 2026, line 9349
S2: Cyproheptadine
- when indicated for allergic rhinitis or antipruritic use.
Consolidated Schedules 06 July 2026, line 1789
Pharmacological class: Antihistaminics. (class 5.7.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Zyactin, Zydus Healthcare (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.